Key result
Various approaches can identify and quantify triglyceride-rich lipoprotein remnants, but more accurate and clinically applicable assays are needed to define coronary artery disease risk.
Design
Review
Authors
Loading...
Current methods insufficient for routine use; leaves open accurate CAD risk definition in hypertriglyceridemia until better assays emerge.
This review highlights the characteristics of triglyceride-rich lipoprotein remnants and the need for more accurate assays to define coronary artery disease risk in patients with hypertriglyceridemia.
Cohn et al. (1999) conducted a review in Hypertriglyceridemia. Triglyceride-rich lipoprotein remnant assays was evaluated. Various approaches can identify and quantify triglyceride-rich lipoprotein remnants, but more accurate and clinically applicable assays are needed to define coronary artery disease risk.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: